Olsson Shawn
SEC insider (Form 3/4/5 filer). CIK 0002015796. Chief Commercial Officer at LENZ Therapeutics, Inc. (LENZ). 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SOLANA BEACH, CA.
Companies Olsson Shawn has filed insider reports for
- LENZ Therapeutics, Inc. (LENZ): Officer, Chief Commercial Officer
Olsson Shawn
CIK: 0002015796
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LENZ Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectRestricted Stock Unit
14K shares- - Jan 2, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
84.2K shares- - Nov 17, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect5.8K shares at avg. $26.37$153K - Nov 17, 2025LENZ
LENZ Therapeutics, Inc.
ExerciseDirect10K shares at avg. $2.08$21K - Nov 17, 2025LENZ
LENZ Therapeutics, Inc.
SaleDirect4.2K shares at avg. $25.74$108K - Apr 9, 2025LENZ
LENZ Therapeutics, Inc.
ExerciseDirect1.4K shares at avg. $2.08$3K - Jan 9, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
80.1K shares- - Dec 16, 2024LENZ
LENZ Therapeutics, Inc.
ExerciseDirect3.3K shares at avg. $2.08$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | Award Restricted Stock Unit | 14,000 | - | - | Direct |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 84,200 | - | - | Direct |
| Nov 17, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 5,788 | $26.37 | $152,612 | Direct |
| Nov 17, 2025 | LENZ LENZ Therapeutics, Inc. | Exercise | 10,000 | $2.08 | $20,800 | Direct |
| Nov 17, 2025 | LENZ LENZ Therapeutics, Inc. | Sale | 4,212 | $25.74 | $108,411 | Direct |
| Apr 9, 2025 | LENZ LENZ Therapeutics, Inc. | Exercise | 1,400 | $2.08 | $2,912 | Direct |
| Jan 9, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 80,100 | - | - | Direct |
| Dec 16, 2024 | LENZ LENZ Therapeutics, Inc. | Exercise | 3,333 | $2.08 | $6,933 | Direct |
1-8 of 8 transactions